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Abstract
The study aimed at assessing the acute physiological effects of running a 65-km vs a 107-
km mountain ultramarathon. Nineteen athletes (15 males and 4 females) from the shorter
race and forty three athletes (26 males and 17 females) from the longer race were enrolled.
Body weight, respiratory and lower limb strength were assessed before and after the race.
Blood samples were obtained before, after and 24-h post-race. Body weight loss did not dif-
fer between races. A decrease in squat jump height (p<0.01; d = 1.4), forced vital capacity
(p<0.01; d = 0.5), forced expiratory volume in 1 s (p<0.01; d = 0.6), peak inspiratory flow
(p<0.01; d = 0.6) and maximal inspiratory pressure (p<0.01; d = 0.8) was observed after the
longer race; while, after the shorter race only maximal inspiratory pressure declined
(p<0.01; d = 0.5). Greater post-race concentrations of creatine kinase (p<0.01; d = 0.9) and
C-reactive protein (p<0.01; d = 2.3) were observed following the longer race, while high-sen-
sitivity cardiac troponin was higher after the shorter race (p<0.01; d = 0.3). Sodium
decreased post-competition only after the shorter race (p = 0.02; d = 0.6), while creatinine
increased only following the longer race (p<0.01; d = 1.5). In both groups, glomerular filtra-
tion rate declined at post-race (longer race: p<0.01, d = 2.1; shorter race: p = 0.01, d = 1.4)
and returned to baseline values at 24 h post-race. In summary, expiratory and lower-limb
fatigue, and muscle damage and inflammatory response were greater following the longer
race; while a higher release of cardiac troponins was observed after the shorter race. The
alteration and restoration of renal function was similar after either race.
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Aparicio I, Priego-Quesada JI, Pérez-Soriano P,
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1. Introduction
The popularity of mountain ultramarathons (MUM) has grown exponentially during the last
few years [1, 2] and they constitute an outstanding model for the study of the acute conse-
quences of ultra-endurance exercise on human body physiology [3]. Indeed, several investiga-
tions have documented the effects of running a MUM on lower-limb neuromuscular fatigue
[4–7], respiratory fatigue [8, 9], cardiac damage [10–13], renal function and inflammatory
activity [4, 14–18]. These data is important for both medical and coaching communities, to
increase the knowledge of potential side effects and a harmful influence on health of running a
MUM [19], on one hand; and, on the other hand, to help coaches to better plan their athletes’
training sessions following the race [20]. However, a considerably lower number of studies
have compared how MUM distance may affect the abovementioned responses [5, 21].
It has been suggested that extremely long distance MUM (i.e., 330-km) provoke lesser neu-
romuscular fatigue, muscle damage and inflammation than shorter ones (i.e., 110–166 km)
[5]. This might be explained because runners adopt a more conservative pacing strategy
according to the distance to avoid early abandonment and preserve muscle integrity [22, 23].
When comparing mountain races of ~50 km and ~100 km, it appears that longer races induce
greater inflammatory and muscle damage responses while cardiac damage biomarkers release
is lower [21]. On the other hand, significant reductions in expiratory pulmonary function have
been reported following both a 110-km [9] and a 330-km MUM [8]. Nevertheless, most of
those studies have focused their analyses on a specific physiological response; so further studies
that integrate biochemical data, lower-limb and respiratory fatigue variables are needed to
improve the interpretation of the results. Having a broader picture of how ultramarathon dis-
tance competition affects physiology and performance could ease the understanding of ath-
letes’ in-race performance and post-race recovery [22].
The aim of our study was, therefore, to assess the acute physiological effects of running a
65-km vs a 107-km MUM from an integrative perspective. Specifically, we were interested in
analyzing and comparing body weight loss and sodium depletion, lower-limb and respiratory
fatigue, renal function, muscle damage and inflammatory activity, and cardiac damage follow-
ing the two races. Our hypotheses were the following: (1) body weight loss and sodium deple-
tion would be greater following the shorter race; (2) lower-limb and respiratory fatigue would
be greater after the longer race; (3) renal alteration, muscle damage and inflammatory
response may be greater following the longer race; (4) a higher release of cardiac troponin
would be observed after the shorter race.
2. Material and methods
2.1 Experimental design
Two different races were studied (Costa Blanca Trails, November 2018; and Penyagolosa
Trails, April 2019). Costa Blanca Trails race consisted of a 65 km circular route with a total
positive elevation of 4200 m. Penyagolosa Trails race consisted of a 107.4 km non-circular
route, starting at an altitude of 40 m and finishing at 1,280 m above the sea level, with a total
positive and negative elevation of 5604 and 4356 m respectively. In line with the literature [2],
participants in each of these two races will be henceforth referred as long trail (LT) and ultra
trail (UT) runners, respectively. Measurements were performed with the same equipment, fol-
lowing the same procedures and by the same group of researchers. The day before the race,
body composition, respiratory and lower limb strength assessments were conducted and a
blood sample was collected. After the race, body weight (BW), respiratory and lower limb
strength assessments were repeated and a second blood sample was collected. Lastly, a third
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blood sample was collected 24-h following the race. In both races, finishing times were
obtained from race results and mean flat-equivalent running speed was calculated according
to the procedure established by Saugy et al. [5].
2.2. Participants
All participants from both races received an invitation email to participate in the study. Those
individuals who accepted the invitation were contacted by telephone and fully informed about
the study procedure and inclusion criteria. Nineteen athletes (15 males and 4 females) and
forty three athletes (26 males and 17 females) were selected from the LT and the UT races
respectively to participate in the study, according to the following inclusion criteria: having
previously completed at least one ultramarathon (>42 km); being free from cardiac or renal
disease and from taking any medication on a regular basis. All subjects gave their written con-
sent to participate and were also allowed to withdraw from the study at will. The same ques-
tionnaire was used to collect demographic and medical information as well competition
history and training data from the three months prior to the race for both samples. The investi-
gation was conducted in accordance with the Declaration of Helsinki and approval for the
project was obtained from the research Ethics Committee of the University Jaume I of Castel-
lon (Expedient Number CD/007/2019). This study is enrolled in the ClinicalTrails.gov data-
base, with the code number NCT03990259 (www.clinicaltrials.gov).
2.3. Body composition
Body Mass Index (BMI) and percentage of fat mass (%FM) were evaluated using a bioelectrical
impedance weight scale (Tanita BC-780MA, Tanita Corp., Tokyo, Japan). Measurements were
performed in a fasted state with minimal clothing (running shorts and t-shirt), following the
manufacturer’s guidelines. The skin and the electrodes were cleaned and dried before testing.
Additionally, as in previous studies [24, 25], we also measured pre-race and immediately post-
race body weight (BW) with the runner clothed in running wear and shoes (other items such as
waist packs and hydration vests were removed and nothing was permitted in the runner’s hands).
2.4. Respiratory assessment
Pulmonary function testing was conducted using a portable desktop spirometer (Pony FX,
Cosmed, Rome, Italy), with the participant seated and wearing a nose-clamp, in line with the
American Thoracic Society and European Respiratory Society guidelines for spirometry stan-
dardization [26]. Measurements were performed the day before the race and within 15 min
after the race by the same experienced investigator to ensure that maneuvers were carried out
properly [27]. Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC
ratio and peak expiratory flow (PEF) were determined from the maximal flow volume loop
(MFVL). Each participant performed three acceptable MFVL maneuvers lasting 6 s or longer
each one. The spirometric maneuver with the highest sum of FVC and FEV1 was accepted.
Furthermore, maximal inspiratory pressure (MIP) was measured to assess volitional maximal
inspiratory strength using a handheld electronic device (Powerbrathe K5, HaB International
Ltd, UK). This instrument has shown to be reliable [28]. Each participant performed three
attempts and the best result was considered for analysis.
2.5. Lower limb strength assessment
Lower limb strength was evaluated using a squat jump (SJ) test. Participants were asked to
jump as high as possible from a starting position with hips and knees flexed 80 degrees and
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hands stabilized on hips to avoid arm-swing. Jump height was estimated by the flight time
measured with a contact platform (Chronojump, Barcelona, Spain) [29]. The test was per-
formed twice, with a 90-seconds rest period between attempts [30]. Each individual’s best per-
formance was retained for statistical analysis.
2.6. Blood sampling and analysis
Blood samples were collected from an antecubital vein by venipuncture using BD Vacutainer
PST II tubes. Samples were centrifuged at 3500 rpm for ten minutes and kept at 4˚C during
transport to Vithas Rey Don Jaime Hospital (Castellon), where they were processed using the
modular platform Roche / Hitachi clinical chemistry analyzer Cobas c311 (Roche Diagnostics,
Penzberg, Germany), as previously published [13, 31, 32]. Biochemical results obtained imme-
diately post-race were adjusted by employing the Dill and Costill method [33], using hemato-
crit and hemoglobin to determine the magnitude of plasma volume changes after the race in
each participant [33, 34]. The following blood variables were considered for analysis: lactate
dehydrogenase (LDH), creatine kinase (CK), sodium [Na+], C-reactive protein (CRP), Creati-
nine (Cr) and high sensitivity cardiac troponin (Hs-TNT). Moderate hyponatremia was
defined as [Na+] lower than 129 mmol/L and mild hyponatremia as [Na+] between 129 and
134 mmol/L [16, 35]. Additionally, the Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation was used to calculate the glomerular filtration rate (GFR) [36]; and
according to the Risk, Injury, Failure, Loss of function, and End-stage renal disease (RIFLE)
classification [37], a GFR decrease greater than 25% from baseline was considered indicative
of risk of Acute Kidney Injury (AKI). Hs-TNT was measured quantitatively with the new
high-sensitive enzyme immunoassay based on electrochemiluminescence technology
(ECLIA), using a Cobas e411 analyzer (Roche Diagnostics, Penzberg, Germany). The Limit of
the Blank (LoB) of this assay is 3 ng/L and the Upper Reference Limit (URL), defined as the
99th percentile of a healthy population, 14 ng/L. The approximate hs-TnT equivalent to the
upper limit of 30 ng/L for the 4th generation cardiac troponin T assay is 50 ng/L [38].
2.7. Statistical analysis
Statistical analyses were carried out using the Statistical Package for the Social Sciences soft-
ware (IBM SPSS Statistics for Windows, version 22.0, IBM Corp., Armonk, NY). Normal dis-
tribution of the variables was verified through the Kolmogorov-Smirnov test (p<0.05). Blood
variables and training and competition related data did not present a normal distribution, so
non-parametric statistics were applied to assess these variables. Flat-equivalent running speed,
pre-to-post change in BW and body composition variables (BMI and %FM) were compared
between UT and LT runners using Student’s t-tests. Training and competition related data
were compared between the two groups using Mann-Whitney U and Chi-Square tests.
A two-factor repeated-measures ANOVA was conducted, with ‘Fatigue’ (pre-race vs post-
race) as within-factor and ‘Race’ (UT vs LT) as between-factor, to assess the evolution of respi-
ratory variables (FVC, FEV1, FVC/FEV1 PEF, MIP) and SJ in the two groups. Friedman tests
were conducted to appraise the evolution of blood variables (Cr, GFR, [Na+], CK, LDH, CRP
and hs-TNT) from pre-race to 24 h post-race in each group (UT vs LT). Pairwise comparisons
were performed using Bonferroni’s test (normally distributed variables) and Mann-Whitney U
and Wilcoxon tests (non-normally distributed variables). Categorical data (natremic status,
AKI risk and hs-TNT upper/below the URL) were analyzed by means of Chi-Square tests. The
meaningfulness of the outcomes was estimated through the partial estimated effect size (η2
partial) for ANOVA and Cohen’s d effect size for pairwise comparisons. In the latter case, a
Cohen’s D between 0.3–0.5 was considered small; between 0.5–0.8, moderate; and greater than
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0.8, large [39]. The significance level was set at p-value <0.05 and data are presented as means
and standard deviations (±SD).
3. Results
Thirty-two athletes (19 males and 13 females) completed the UT race with an average finish
time of 21 h 23 min ± 3 h 28 min (167 ± 29% of winning time), while seventeen athletes (13
males and 4 females) completed the LT race with an average finish time of 11 h 1 min ± 1 h 41
min (146 ± 21% of winning time). The finishers/starters ratio in our sample was 74.4% and
89% for the UT and LT races. Considering all race participants, the finishers/starters ratios
were 73.8% and 92.5% respectively, while the average finish times were 20 h 24 min ± 3 h 11
min and 11 h 29 min ± 1 h 55 min. Mean flat-equivalent running speed was significantly
higher in LT compared to UT runners (9.92 ± 1.48 vs 5.75 ± 1.04 km/h; p<0.01; d = 3.5).
Change in BW was not significantly different between UT and LT groups (1.5 ± 2.1% vs
2.4 ± 1.6; p = 0.12; d = 0.5).
Body composition data, training and competition related data from finishers of UT and LT
are compared in Table 1. No significant between-group differences were identified in body
composition variables. On the other hand, UT runners appeared to possess greater training
experience (p = 0.04; d = 0.7) and being finishers of more races longer than 100 km (p<0.01;
d = 0.6). Regarding training-related data of the 3 months prior to the race, no differences were
found either in training days and hours or in running volume and weekly positive elevation.
However, the percentage of runners who performed at least one weekly strength-training was
significantly higher among UT participants (p = 0.02).
Values of expiratory pulmonary function, MIP and SJ at pre-race and post-race in UT and
LT runners are presented in Table 2. Univariate contrast analysis from repeated measures
ANOVA showed a significant effect for ‘Fatigue’ on FVC [F = 5.99; p = 0.02; η2 partial = 0.12],
FEV1 [F = 8.61; p<0.01; η2 partial = 0.17], PEF [F = 7.04; p = 0.01; η2 partial = 0.14], MIP
[F = 64.69; p<0.01; η2 partial = 0.60] and SJ [F = 31.70; p<0.01; η2 partial = 0.41]. On the
other hand, ‘Race’ factor significantly affected MIP [F = 7.20; p = 0.01; η2 partial = 0.14], while
the ’Fatigue x Race’ interaction affected FVC [F = 7.17; p = 0.01; η2 partial = 0.12], FEV1
[F = 9.89; p<0.01; η2 partial = 0.19], PEF [F = 8.157; p<0.01; η2 partial = 0.16], MIP [F = 4.77;
p = 0.03; η2 partial = 0.10] and SJ [F = 7.40; p<0.01; η2 partial = 0.14]. Bonferroni adjusted
Table 1. Characteristics of ultra trail and long trail participants (mean ± SD).
UT (n = 32) LT (n = 17) UT vs. LT
p-value Cohen’s D
Age (years) 41 ± 6 41 ± 7 0.85 0.1
BMI (kg/m2) 22.8 ± 2.0 23.6 ± 2.5 0.27 0.3
FM (%) 15.4 ± 4.9 14.9 ± 4.8 0.73 0.1
Number of years running 8 ± 3 6 ± 3 0.04 0.7
Number of races >100 km 2 ± 3 1 ± 2 <0.01 0.6
Weekly training days 5 ± 1 5 ± 1 0.51 0.1
Weekly running volume (km) 70 ± 22 58 ± 24 0.16 0.6
Weekly positive elevation (m) 1772 ± 691 1493 ± 708 0.36 0.4
Weekly training hours 10 ± 4 9 ± 5 0.45 0.1
Strength training (yes/no) 81% / 19% 47% / 53% 0.02 -
Abbreviations: BMI, Body Mass Index; FM, fat mass; Strength training (yes/no), percentage of participants who performed at least one weekly lower-limb strength
training in the previous 3 months.
https://doi.org/10.1371/journal.pone.0238846.t001
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pairwise comparisons showed that, among UT participants, all respiratory variables showed a
significant decline following the race: FVC (p<0.01; d = 0.5), FEV1 (p<0.01; d = 0.7), FEV1/
FVC ratio (p = 0.03; d = 0.6), PEF (p<0.01; d = 0.6) and MIP (p<0.01; d = 0.8). Conversely, no
significant pre-to-post changes were identified among LT participants regarding respiratory
variables, except for MIP (p<0.01; d = 0.5). In addition, at post-race, LT runners displayed sig-
nificantly higher values of MIP, compared with UT runners. Similarly, the UT group, unlike
the LT group, evidenced a significant reduction in SJ performance following the race (p<0.01;
d = 1.4); moreover, at post-race, a significant between-groups difference in SJ emerged.
Friedman analysis revealed significant differences in the evolution of Cr only among UT
runners (χ2(2) = 54.83, p<0.01). Subsequent Mann-Whitney U analyses revealed that Cr signif-
icantly increased at post-race (p<0.01, d = 1.5) and decreased at 24 h post-race (p<0.01, d =
1.2), but remained significantly elevated compared to pre-race (p = 0.01, d = 0.3). In addition,
post-race Cr was significantly higher in UT runners compared with the LT group (p<0.01, d =
0.9). Significant differences were noted in the two groups in the evolution of GFR (UT: χ2(2) =
49.00, p<0.01; LT: χ2(2) = 12.00, p<0.01) (Fig 1A). Both groups showed a significant reduction
in GFR following the race (p<0.01, d = 2.1; p = 0.01, d = 1.4; respectively) and a subsequent
increase at 24 h post-race (p<0.01, d = 1.5; p<0.01, d = 0.9; respectively). No between-groups
differences were identified in the percentage of runners who met the risk criteria for AKI at
post-race (LT: 44%, UT: 56%; p = 0.42) and at 24-h post-race (LT: 7%, UT: 0%; p = 0.13). Sig-
nificant differences were observed in the two groups in the evolution of [Na+] (UT: χ2(2) =
10.43, p<0.01; LT: χ2(2) = 10.43, p<0.01) (Fig 1B). At post-race, however, only LT runners
showed significantly reduced values of [Na+] (p = 0.03, d = 0.6). At 24 h post-race in both
groups [Na+] was significantly above pre-race levels (p<0.01, d = 0.8; p<0.01, d = 1.2; respec-
tively). Moreover, [Na+] was significantly higher in LT runners as compared with UT group
(p<0.01, d = 1.2) at that time point. No between-groups differences were identified in the dis-
tribution of normonatremic, mild hyponatremic and moderate hyponatremic cases at post-
race (LT: 76%/12%/12%; UT: 97%/3%/0%; p = 0.42).
Table 2. Spirometric-derived data, maximal inspiratory pressure and squat jump at pre-race and post-race in ultra trail and long trail participants (mean ± SD).
UT LT UT vs LT
(n = 32) (n = 17) p-value Cohen’s D
FVC (l) PRE-RACE 4.42 ± 0.98 4.19 ± 0.93 0.55 0.3
POST-RACE 3.91 ± 1.01 �� 4.21 ± 0.86 0.35 0.3
FEV1 (l) PRE-RACE 3.45 ± 0.74 3.29 ± 0.78 0.51 0.2
POST-RACE 2.88 ± 0.99 �� 3.31 ± 0.73 0.14 0.5
FEV1/FVC (%) PRE-RACE 78.52 ± 4.92 77.88 ± 7.77 0.74 0.1
POST-RACE 72.45 ± 13.98 �� 78.13 ± 9 0.15 0.5
PEF (l/min) PRE-RACE 8.08 ± 2.22 7.39 ± 1.8 0.29 0.3
POST-RACE 6.72 ± 2.56 �� 7.44 ± 1.95 0.33 0.3
MIP (cm H2O) PRE-RACE 100 ± 28 115 ± 24 0.06 0.6
POST-RACE 80 ± 24 �� 103 ± 22 �� <0.01 1.0
SJ (cm) PRE-RACE 24.2 ± 4.1 24.4 ± 3.7 0.90 0.1
POST-RACE 18.4 ± 4.2 �� 22.3 ± 4.6 <0.01 0.9
Abbreviations FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; PEF, Peak expiratory flow; MIP, maximal inspiratory pressure; SJ, squat jump.
� Significantly different from pre-race (p<0.05);
�� Significantly different from pre-race (p<0.01).
https://doi.org/10.1371/journal.pone.0238846.t002
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Fig 1. Glomerular filtration rate (panel A), sodium (panel B), creatine kinase (panel C), lactate dehydrogenase (panel D), C-
reactive protein (panel E) and high sensitivity cardiac troponin (panel F) evolution from pre-race to 24-h post race in Long Trail
runners (grey boxes) and Ultra Trail runners (white boxes). � Significantly different from pre-race (p<0.05). # Significantly different
from Long Trail runners (p<0.05). ¥ Significantly different from the preceding time point (p<0.05).
https://doi.org/10.1371/journal.pone.0238846.g001
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Significant differences were identified in the two groups in the evolution of CK (UT: χ2(2) =
58.56, p<0.01; LT: χ2(2) = 21.57, p<0.01) (Fig 1C). It significantly increased at post-race in
both groups (p<0.01, d = 1.7; p<0.01, d = 0.6; respectively) and remained significantly ele-
vated compared to pre-race (p<0.01, d = 1.5; p<0.01, d = 0.7; respectively). However, in UT
runners, but not in LT runners, it significantly decreased from post-race to 24 h post-race
(p<0.01, d = 0.7). Besides, post-race CK was significantly higher in UT runners as compared
with LT group (p<0.01, d = 0.9). Significant differences were noted in the two groups in the
evolution of LDH (UT: χ2(2) = 58.56, p<0.01; LT: χ2(2) = 22.43, p<0.01) (Fig 1D). In both
groups, it significantly increased at post-race (p<0.01, d = 2.3; p<0.01, d = 1.6; respectively)
and dropped at 24 h post-race (p<0.01, d = 0.5; p = 0.01, d = 0.9; respectively), but remained
significantly elevated compared to pre-race (p<0.01, d = 1.6; p = 0.01, d = 0.8; respectively). At
24 h post-race LDH was significantly higher in UT runners compared with the LT group
(p = 0.04, d = 0.50).
Significant differences were observed in the two groups in the evolution of CRP (UT: χ2(2)
= 58.56, p<0.01; LT: χ2(2) = 28.00, p<0.01) (Fig 1E). In both groups, it significantly increased
from pre-race to post race (p<0.01, d = 2.6; p<0.01, d = 0.6; respectively) and from post-race
to 24 h post-race (p<0.01, d = 1.6; p<0.01, d = 2.1; respectively). Post-race CRP was signifi-
cantly higher in UT runners as compared with LT group (p<0.01, d = 2.3). Lastly, significant
differences were noted in the two groups in the evolution of hs-TNT (UT: χ2(2) = 57.75,
p<0.01; LT: χ2(2) = 24.57, p<0.01) (Fig 1F). In both groups, it significantly increased at post-
race (p<0.01, d = 1.0; p<0.01, d = 2.9; respectively) and dropped at 24 h post-race (p<0.01, d
= 0.7; p<0.01, d = 2.3; respectively), but remained significantly elevated compared to pre-race
(p<0.01, d = 0.9; p = 0.02, d = 1.1; respectively). Post-race hs-TNT was significantly higher in
LT runners compared with the UT group (p<0.01, d = 0.3), although no between-groups dif-
ferences were identified in the percentage of runners who surpassed the URL at post-race (LT:
77%, UT: 57%; p = 0.149) and at 24-h post-race (LT: 22%, UT: 13%; p = 0.44).
4. Discussion
The aim of this study was to assess the acute physiological effects of running a 107-km MUM,
compared with a shorter 65-km MUM. Our first hypothesis was partially confirmed. No differ-
ences were observed regarding pre-to-post change in BW; but runners from the LT, unlike the
UT group, evidenced a decrease in [Na+] following the race. Secondly, as hypothesized, UT
runners showed greater post-race lower-limb and respiratory fatigue. Regarding biochemical
variables, GFR returned to baseline values at 24 h post-race in both groups; muscle damage
and inflammatory response was greater among UT runners, as predicted; and lastly, confirm-
ing our fourth hypothesis, acute release of hs-TNT was higher among LT runners.
Given the combination of substrate utilization and the liberation of glycogen-bound water
during exercise, it has recently been argued that BW losses between 2–5% seem advisable to
sustain body water balance and maintain euhydration during ultramarathons [40]. Our data
was within this range for LT runners (2.41 ± 1.62%), however BW loss among the UT group
was slightly lower (1.47 ± 2.14%). We hypothesized that BW loss would be greater following
the shorter race as BW change has been positively correlated with running speed [24, 41, 42].
Our results showed that running speed was significantly higher in LT compared to UT run-
ners, but the difference in BW change between groups did not reach statistical significance.
On the other hand, only LT runners evidenced a decrease in [Na+] following the race. Indeed,
4 participants (23.5%) from LT race exhibited EAH (2 moderate hyponatremia and 2 mild
hyponatremia), compared with only one case (3.1%) of mild hyponatremia among UT partici-
pants. None of those participants required medical attention and the incidence was within the
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rates previously reported in the field [41], even though one of the mild hyponatremic runners
also presented a post-race CK indicative of rhabdomyolysis (11089 U/L). This latter result may
support a previously suggested link between rhabdomyolysis and EAH [16, 43, 44].
Previous studies assessing respiratory fatigue following MUM have reported a significant
reduction in expiratory pulmonary function irrespective of race length [8, 9]. Our results
extend these previous studies to show that a LT (i.e. 65-km), unlike mountain races longer
than 100 km, did not provoke significant fatigue in expiratory pulmonary function. However,
MIP was significantly reduced following both races. These findings suggest that inspiratory
muscle strength is more sensitive to fatigue subsequent to running a MUM, compared with
expiratory pulmonary function [9, 45]. Hence, the addition of specific MIP training into the
daily routine of these athletes might improve their performance [46, 47].
As noted in the introduction, it has been suggested that extremely long MUM (i.e., 330-km)
provoke lesser lower-limb neuromuscular fatigue than shorter ones (i.e., 110–166 km) [5]. Yet,
no previous studies, as far as we are aware, had compared strength loss following a LT com-
pared to an UT. Our results show that SJ performance only decreased following the UT. There-
fore, it seems that lower-limb strength loss increases correlative with MUM distance until it
reaches a plateau [5, 48], and is lower in extremely long MUM probably as a consequence of a
more conservative pacing strategy adopted by runners in such races [22, 23]. The absence of a
pre-to-post change in SJ performance among LT runners contrasts, however, with a previous
study conducted on a similar race (75 km with a total positive elevation of 3930 m) [6], where
the authors reported a significant reduction of 20% in counter-movement jump (CMJ) height.
Notwithstanding, differences in execution technique and muscle involvement between SJ and
CMJ could explain such disagreement.
Concerning muscle damage, LDH release pattern was consistent following both races and
coincides with previous studies in MUM [4, 18, 21]. It peaked immediately post-race and
dropped at 24 h post-race, although its values remained significantly different from pre-race.
The higher LDH concentration at 24 h post-race in UT runners, as compared with the LT
group, also agrees with Rubio-Arias et al. [21] study. Regarding CK, Rubio-Arias et al. [21]
found that post-race concentration was significantly higher following a 111-km MUM com-
pared to a 54-km MUM, although runners from both races reached peak CK values immedi-
ately post-race and lowered these values at 24 h post-race. Our results concur showing higher
CK values following the longer race; however, in our study the release pattern differs between
UT and LT runners. CK peaked at post-race among UT runners and decreased at 24 h post-
race, while LT runners showed an increase in CK from post-race to 24 h post-race. Previous
studies on half and full road marathons have reported peak values of CK at 24-h post-race [31,
49]; while following longer MUM (i.e., 166-km), peak CK has been described to occur imme-
diately post-race [4, 50]. In addition, during a flat 200-km race CK was reported to signifi-
cantly increase from 19-fold pre-race value at mid race to 90-fold pre-race value at the end of
the race [51]; similarly, a continuous rise in CK has been described during a 217-km MUM
[52]. However, it seems that there is not an unanimous CK release pattern following endur-
ance events longer than 42-km but shorter than 166-km. Differences between studies regard-
ing samples’ training level and the ratio between distance and altitude change of the races
could explain this disagreement. Regarding inflammatory response, both the results from
Rubio-Arias et al. [21] and ours display a greater response following the longer race and an
increase in CRP from post-race to 24 h post-race measurement. Notwithstanding, differences
between UT and LT runners in CK and CRP in our study were significant only at post-race,
whereas in the Rubio-Arias et al. [21] study they remained significant at 24-h post-race.
Muscle damage and inflammatory responses after running a MUM rarely results in adverse
consequences among athletes; however, the release of excessive amounts of intramuscular
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proteins into the blood stream may negatively affect renal function, mainly in conditions of
heat stress, dehydration, underlying renal problems, use of nonsteroidal anti-inflammatory
drugs and inadequate training [19, 53]. Our results showed that in 56% of UT runners and
44% of LT the evolution of GFR from pre-to-post race met the risk criteria for AKI, without
significant differences between races. Nevertheless, none of the participants in the study expe-
rienced an adverse event requiring medical attention during the race or within the first 24-h
post-race. Moreover, no UT runner and only one LT runner met the criteria for AKI at 24-h
post race. Similar results at post-race and 24-h post-race have been previously described fol-
lowing a multi-stage ultramarathon [17], a 104-km MUM [16], a 67-km MUM [18], a road
marathon [32, 54] and a road half-marathon [55]. Therefore, it seems that no long-term renal
function repercussions are expected following either road half & full marathons, or MUM.
Exercise-associated release of cardiac troponins has been postulated to be mainly related to
exercise intensity (i.e., as opposed to exercise volume) [13, 56–59]. This fact could explain why
post-race hs-TNT was higher among UT runners, as opposed to the results of muscle damage
and inflammation biomarkers. Nevertheless, the difference in the percentage of runners (LT:
77%, UT: 57%) with post-race values of hs-TNT above the URL did not reach statistical signifi-
cance and most of the runners in the two races displayed values below the URL at 24 h post-
race (LT: 78%, UT: 87%). This rate of normalization (i.e., percentage of participants with hs-
TNT values below the URL at 24 h post-race) is similar to the one previously reported follow-
ing a road marathon (between 73 and 83%) [60–62] and a 91-km mountain bike race (82%)
[58].
5. Conclusions
Our results suggest that expiratory pulmonary capacity and lower-limb strength are more
fatigued following a longer MUM, while inspiratory strength loss is independent of distance.
Acute muscle damage and inflammatory response appear to be greater following a longer
MUM, although those differences disappear at 24-h post-race. Moreover, a different time-
course of CK response was observed, in UT runners it peaked immediately post-race while in
LT runners it did at 24-h post-race. On the other hand, the shorter race elicited a higher acute
cardiac troponin release, yet the difference in the percentage of participants with values above
the URL was not significant. Lastly, renal response seems not be affected by distance competi-
tion. None of the participants in the study required medical attention during the race or within
the first 24-h post-race. Overall, our results provide a comprehensive view of how mountain
ultramarathon distance competition may affect respiratory and lower-limb performance, car-
diac, inflammatory, muscle damage and renal acute responses. On one hand, those outcomes
could ease doctors with the interpretation of analytical values of ultratrail runners following a
race. On the other hand, the knowledge of how muscle damage, respiratory capacity and
lower-limb strength are affected by distance competition should be considered by coaches
when planning their athletes’ training for those events.
The main limitation of the study was the comparison of two different sample sets for the
two races. Notwithstanding, no between-groups differences were identified in age, body com-
position and endurance training data, so we consider that the results obtained are consistent
enough to reach the abovementioned conclusions. Future studies should explore the effect of
MUM distance in a same sample of athletes to corroborate our results.
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